Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Clinical trials demonstrated significant weight reduction in non-diabetic participants
Zepbound is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for chronic weight management in adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or 27 kg/m or greater (overweight) with at least one weight-related comorbidity
However, it's crucial to consult with a healthcare professional
Semaglutide + tirzepatide, or semaglutide + retatrutide
J Clin Oncol
For everyone else, 10mg represents the optimal risk-benefit intersection
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
